SPDR S&P Biotech ETF $XBI Shares Sold by Means Investment CO. Inc.

Means Investment CO. Inc. reduced its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 65.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,822 shares of the exchange traded fund’s stock after selling 11,012 shares during the quarter. Means Investment CO. Inc.’s holdings in SPDR S&P Biotech ETF were worth $918,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Elite Wealth Management Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $14,076,000. Endowment Wealth Management Inc. boosted its position in shares of SPDR S&P Biotech ETF by 20.3% during the 3rd quarter. Endowment Wealth Management Inc. now owns 7,709 shares of the exchange traded fund’s stock valued at $1,216,000 after acquiring an additional 1,300 shares during the last quarter. StoneX Group Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 52.3% in the third quarter. StoneX Group Inc. now owns 7,642 shares of the exchange traded fund’s stock valued at $1,205,000 after purchasing an additional 2,624 shares during the period. Investment Management Corp VA ADV grew its holdings in shares of SPDR S&P Biotech ETF by 3.8% in the third quarter. Investment Management Corp VA ADV now owns 8,927 shares of the exchange traded fund’s stock valued at $1,408,000 after purchasing an additional 324 shares during the period. Finally, Tamar Securities LLC grew its holdings in shares of SPDR S&P Biotech ETF by 13.0% in the third quarter. Tamar Securities LLC now owns 82,493 shares of the exchange traded fund’s stock valued at $13,008,000 after purchasing an additional 9,522 shares during the period.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $152.21 on Monday. SPDR S&P Biotech ETF has a 12-month low of $106.30 and a 12-month high of $169.89. The stock has a market cap of $10.41 billion, a P/E ratio of 11.47 and a beta of 0.87. The company has a 50-day moving average price of $155.22 and a 200 day moving average price of $142.29.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.